Close

Analyst Ratings for Beam Therapeutics Inc (BEAM)

BEAM Rating Summary

BEAM Price Target Summary

* Over Last 12-Mos
  |   Expand Research on BEAM
Overall Rating: NEUTRAL   Rating Trend: Up   Avg. $ Target: $50.33 (+47.7%) * Over Last 12-Mos
Rating Score: 4.3 / 10   Percentile Rank: 43%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
1/29/2024 JPMorgan
» Updated 2/27/2024
Eric Joseph Upgrade Overweight
(Neutral)
44.00
(40.00)
24.92
(34.07)
36.72% Details
12/15/2023 BofA Securities Greg Harrison Downgrade Neutral
(Buy)
35.00
(45.00)
29.79
(34.07)
14.37% Details
Like BEAM Ratings? Also take a look at LLY

BEAM Ratings News